Catalyst Wire Dossier Catalyst Wire Dossier

Sirolimus-eluting, heparin-coated CoCr stent

· Cordis US Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sirolimus-eluting, heparin-coated CoCr stent, covering 2007-06-27 to 2007-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION) [Phase 2]

See pricing